Limoncella apple polyphenol extract shines in IBD liver damage study

‘Limoncella’ apple polyphenol extract (LAPE) shows promise in reducing liver and intestinal inflammation in a mouse model of inflammatory bowel disease (IBD), highlighting potential natural treatment pathways

New initiative aims to transform how Alzheimer’s disease is diagnosed, treated across healthcare settings

Members of the AD-RIDDLE consortium announced today that they will begin a new initiative that aims to bridge the gap between Alzheimer’s research, implementation science,

January 31, 2024

Labels reveal the truth: “Ultra-processed” and “high in sugar” deter shoppers

Study highlights that labeling foods as “ultra-processed” can significantly influence US adults’ perceptions of health risks and discourage purchase intentions, especially when labels also indicate

April 9, 2024

AstraZeneca’s Fasenra to challenge GSK’s Nucala in rare vasculitis after FDA nod – Pharmaceutical Technology

Fasenra generated $1.55bn last year, according to AstraZeneca’s financials. Image credit: Alexanderstock23 / Shutterstock. AstraZeneca‘s Fasenra (bevacizumab) is set to challenge GSK’s Nucala (mepolizumab) in

September 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.